Grace Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 1.18 M | $4.08 M | 0.00% | 6.96% |
| AIGH CAPITAL MANAGEMENT LLC | 02/02/2026 | 907.22 K | $3.15 M | 0.00% | 5.70% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 641.99 K | $2.22 M | 83.19% | 3.79% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 494.70 K | $1.71 M | 0.00% | 2.92% |
| CERITY PARTNERS LLC | 02/11/2026 | 422.73 K | $1.46 M | 100.00% | 2.65% |
| VANGUARD GROUP INC | 01/29/2026 | 423.98 K | $1.48 M | 3.64% | 2.50% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 129.78 K | $449.04 K | 53.48% | 0.77% |
| CITADEL ADVISORS LLC | 02/17/2026 | 42.30 K | $147.62 K | 55.13% | 0.25% |
| XTX TOPCO LTD | 02/17/2026 | 30.26 K | $105.61 K | 100.00% | 0.18% |
| MORGAN STANLEY | 02/13/2026 | 25.45 K | $88.05 K | 1,277.06% | 0.15% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 13.77 K | $48.00 K | 100.00% | 0.09% |
| STRATOS WEALTH PARTNERS, LTD. | 01/20/2026 | 11.18 K | $38.69 K | 100.00% | 0.07% |
| NATIONAL BANK OF CANADA /FI/ | 02/17/2026 | 2.72 K | $9.37 K | 0.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1.95 K | $6.73 K | 20.81% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 600 | $2.08 K | 100.00% | 0.00% |
| ROYAL BANK OF CANADA | 02/17/2026 | 543 | $2.00 K | -4.90% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 01/30/2026 | 104 | $360 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 101 | $349 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/12/2026 | 41 | $142 | 0.00% | 0.00% |
| FLAGSHIP HARBOR ADVISORS, LLC | 01/21/2026 | 2 | $7 | 100.00% | 0.00% |
| NBC SECURITIES, INC. | 01/29/2026 | 2 | $6 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/12/2026 | 1 | $3 | 0.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SEACREST WEALTH MANAGEMENT, LLC | 01/12/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLINGTON FINANCIAL ADVISORS, LLC | 02/09/2026 | 0 | $0 | -100.00% | 0.00% |
Grace Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 30 institutional investors and hedge funds held shares of Grace Therapeutics Inc.. The most heavily invested institutionals were:
JANE STREET GROUP, LLC: 167,097
UBS Group AG: 26,301
KESTRA PRIVATE WEALTH SERVICES, LLC: 13,000
OPPENHEIMER & CO INC: 10,000
VANGUARD FIDUCIARY TRUST CO: 8,750
BNP PARIBAS ARBITRAGE, SNC: 7,100
25.56% of Grace Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.63 M shares in the last 24 months. This purchase volume represents approximately $14.26 M in transactions.